trans R-138727-d4, (Prasugrel-d4 Metabolite)(Mixture of Diastereomers)
Application:
trans R-138727-d4, (Prasugrel-d4 Metabolite)(Mixture of Diastereomers) is an active labeled metabolite of prasugrel
Molecular Weight:
353.44
Molecular Formula:
C18H16D4FNO3S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Trans R-138727-d4, (Prasugrel-d4 Metabolite)(Mixture of Diastereomers) are active labeled stereoselective
trans R-138727-d4, (Prasugrel-d4 Metabolite)(Mixture of Diastereomers) References
- Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression. | Lamba, V., et al. 2003. J Pharmacol Exp Ther. 307: 906-22. PMID: 14551287
- Identification of the active metabolite of ticlopidine from rat in vitro metabolites. | Yoneda, K., et al. 2004. Br J Pharmacol. 142: 551-7. PMID: 15148251
- The platelet inhibitory effects and pharmacokinetics of prasugrel after administration of loading and maintenance doses in healthy subjects. | Jakubowski, JA., et al. 2006. J Cardiovasc Pharmacol. 47: 377-84. PMID: 16633079
- Further characterization of the expression in liver and catalytic activity of CYP2B6. | Ekins, S., et al. 1998. J Pharmacol Exp Ther. 286: 1253-9. PMID: 9732386
Inhibitor of:
P2Y12.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
trans R-138727-d4, (Prasugrel-d4 Metabolite)(Mixture of Diastereomers), 1 mg | sc-220298 | 1 mg | $3000.00 |